176 related articles for article (PubMed ID: 27828870)
1. Association of chronic kidney disease with periprocedural myocardial injury after elective stent implantation: A single center prospective cohort study.
Jerkic H; Letilovic T; Stipinovic M; Pocanic D; Catic J; Knotek M
Medicine (Baltimore); 2016 Nov; 95(45):e5381. PubMed ID: 27828870
[TBL] [Abstract][Full Text] [Related]
2. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
[TBL] [Abstract][Full Text] [Related]
3. Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions - is there an association?
Stipinovic M; Percin L; Radonic V; Jerkic H; Jurin I; Letilovic T
Medicine (Baltimore); 2019 Oct; 98(43):e16989. PubMed ID: 31651833
[TBL] [Abstract][Full Text] [Related]
4. Periprocedural myocardial infarction and injury in elective coronary stenting.
Zeitouni M; Silvain J; Guedeney P; Kerneis M; Yan Y; Overtchouk P; Barthelemy O; Hauguel-Moreau M; Choussat R; Helft G; Le Feuvre C; Collet JP; Montalescot G;
Eur Heart J; 2018 Apr; 39(13):1100-1109. PubMed ID: 29365133
[TBL] [Abstract][Full Text] [Related]
5. Impact of albuminuria on the incidence of periprocedural myocardial injury in patients undergoing elective coronary stent implantation.
Osugi N; Suzuki S; Ishii H; Yasuda Y; Shibata Y; Tatami Y; Ota T; Kawamura Y; Okumura S; Tanaka A; Inoue Y; Matsuo S; Murohara T
Am J Cardiol; 2014 Jul; 114(1):42-6. PubMed ID: 24802297
[TBL] [Abstract][Full Text] [Related]
6. Periprocedural myocardial damage during percutaneous coronary intervention: a point-of-care platelet testing and intravascular ultrasound/virtual histology study.
Michalak M; Huczek Z; Filipiak KJ; Roik MF; Kochman J; Opolski G
Kardiol Pol; 2013; 71(4):325-33. PubMed ID: 23788337
[TBL] [Abstract][Full Text] [Related]
7. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
[TBL] [Abstract][Full Text] [Related]
8. Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODIGY trial.
Crimi G; Leonardi S; Costa F; Adamo M; Ariotti S; Valgimigli M
Int J Cardiol; 2016 Jun; 212():110-7. PubMed ID: 27038714
[TBL] [Abstract][Full Text] [Related]
9. Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention.
Vatankulu MA; Murat SN; Demircelik B; Turfan M; Sonmez O; Duran M; Bacaksiz A; Ornek E; Tasal A; Goktekin O
Ren Fail; 2013 Aug; 35(7):931-5. PubMed ID: 23803143
[TBL] [Abstract][Full Text] [Related]
10. Impact of the first-generation drug-eluting stent implantation on periprocedural myocardial injury in patients with stable angina pectoris.
Okada T; Yoshikawa D; Ishii H; Matsumoto M; Hayakawa S; Matsudaira K; Tanaka M; Kumagai S; Hayashi M; Ando H; Amano T; Murohara T
J Cardiol; 2012 Oct; 60(4):264-9. PubMed ID: 22738692
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents.
Miao Y; Yu-Jie Z; Zhi-Jian W; Dong-Mei S; Yu-Yang L; Ying-Xin Z; Fei G; Shi-Wei Y; De-An J
Catheter Cardiovasc Interv; 2012 Sep; 80(3):361-7. PubMed ID: 22419375
[TBL] [Abstract][Full Text] [Related]
12. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
[TBL] [Abstract][Full Text] [Related]
13. The influence of aortic valve calcification on the risk of periprocedural myocardial injury after elective coronary intervention.
Chen ZW; Yang HB; Chen YH; Qian JY; Shu XH; Ge JB
Aging Clin Exp Res; 2015 Oct; 27(5):631-6. PubMed ID: 25739835
[TBL] [Abstract][Full Text] [Related]
14. Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.
Zhang Q; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Kirtane AJ; Zhang RY
Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():616-23. PubMed ID: 26864270
[TBL] [Abstract][Full Text] [Related]
15. Myocardial Injury after Percutaneous Coronary Intervention for In-Stent Restenosis Versus de novo Stenosis.
Shimonaga T; Kurisu S; Watanabe N; Ikenaga H; Higaki T; Iwasaki T; Ishibashi K; Dohi Y; Fukuda Y; Kihara Y
Intern Med; 2015; 54(18):2299-305. PubMed ID: 26370852
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Multidetector Computed Tomography to Predict Periprocedural Myocardial Injury After Percutaneous Coronary Intervention for Chronic Total Occlusion.
Usui E; Lee T; Murai T; Kanaji Y; Matsuda J; Araki M; Yonetsu T; Yamakami Y; Kimura S; Kakuta T
Int Heart J; 2017 Feb; 58(1):16-23. PubMed ID: 28100874
[TBL] [Abstract][Full Text] [Related]
17. Nicorandil for Periprocedural Myocardial Injury in Elective Percutaneous Coronary Intervention: A Meta-Analysis of 10 Randomized Controlled Trials.
Yi B; Luo J; Jiang Y; Mo S; Xiao X; Chen X; Rong J
Angiology; 2020 Aug; 71(7):609-615. PubMed ID: 32295385
[TBL] [Abstract][Full Text] [Related]
18. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Peri-procedural Myocardial Infarction in the Era of High Sensitivity Troponin: A Validation of the Joint ACCF/AHA/ESC/WHF Universal Definition of Type 4a Myocardial Infarction with High Sensitivity Troponin T.
Liou K; Jepson N; Kellar P; Ng B; Isbister J; Giles R; Friedman D; Allan R; Lau A; Pitney M; Ooi SY
Heart Lung Circ; 2015 Jul; 24(7):673-81. PubMed ID: 25697382
[TBL] [Abstract][Full Text] [Related]
20. Association of moderate chronic kidney disease with insufficient improvement of fractional flow reserve after stent implantation.
Sakoda K; Tanaka N; Hokama Y; Hoshino K; Murata N; Yamashita J; Yamashina A
Catheter Cardiovasc Interv; 2016 Aug; 88(2):E38-44. PubMed ID: 26489880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
